Skip to Main content Skip to Navigation
Theses

Développement d’outils analytiques de mise en évidence de biomarqueurs d’une exposition aux nouvelles substances psychoactives (NPS) : approches in vivo, in silico, in vitro

Abstract : Owing to wild e-commerce diffusion, alleging safety and legal alternative to usual drugs of abuse arguments, the new psychoactive substances (NPS) are emerging phenomenon in the world. In our societies, through various consecutive challenges (legislation, prevention, …), the ability to identify NPS in biological samples exhibits numerous analytical pitfalls: new substances which are not referenced in the usual commercial mass spectrometric libraries, unknown metabolism (with sometimes active metabolites), sometimes very low active dosages and consecutively low concentrations in blood or urine. In this context, clinical and forensic toxicological analyses in biological samples are routinely performed in our laboratory using two main analytical devices: liquid chromatography-tandem mass spectrometry (LC-MS/MS) for targeted screening and liquid chromatography-high resolution mass spectrometry (LC-HRMS) for non-targeted screening. This last technique is based on the accurate mass (together with isotopic pattern and retention time) of sample components, from which the chemical formula is calculated and searched against a database of mass spectra using dedicated software. The aim of my thesis is to characterize NPS and metabolites (in order to increase the spectral database) using a strategy combining in vitro, in silico, and in vivo approaches. Therefore, the main goal is to increase the detection sensitivity of the NPS use by focusing on the metabolites that are most often the major products of NPS elimination. For this purpose, an in vitro method designed to produce NPS metabolites using human liver microsomes incubations was applied. Obtained metabolites, after confrontation with metabolites in silico predicted, were saved in database. This approach was subsequently confronted with analysis of tablets or other non-biological product containing NPS, but also, with in vivo observed data from NPS exposure: intoxication cases, experimental studies and prospective and retrospective epidemiological studies in targeted population or not … All in all, this work based on this in vitro, in silico and in vivo strategy allowed me to enhance our high resolution spectra database (HRMS) for non-targeted screening and also our spectra database for targeted screening (MS/MS). Today, our HRMS device, with a database that was increased with 83 new NPS and 281 metabolites for the duration of my thesis, is an efficient analytical tool for NPS use detection.
Document type :
Theses
Complete list of metadatas

Cited literature [181 references]  Display  Hide  Download

https://tel.archives-ouvertes.fr/tel-02044100
Contributor : Abes Star :  Contact
Submitted on : Thursday, February 21, 2019 - 12:05:10 PM
Last modification on : Sunday, October 25, 2020 - 7:07:09 AM
Long-term archiving on: : Wednesday, May 22, 2019 - 4:37:39 PM

File

2018LILUS024.pdf
Version validated by the jury (STAR)

Identifiers

  • HAL Id : tel-02044100, version 1

Citation

Camille Richeval. Développement d’outils analytiques de mise en évidence de biomarqueurs d’une exposition aux nouvelles substances psychoactives (NPS) : approches in vivo, in silico, in vitro. Médecine humaine et pathologie. Université du Droit et de la Santé - Lille II, 2018. Français. ⟨NNT : 2018LIL2S024⟩. ⟨tel-02044100⟩

Share

Metrics

Record views

191

Files downloads

95